Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketosis and Exercise Effects on BDNF and Cognition
NCT07218497Phase 1Not yet recruiting
- Sponsor
- University of Southern California
- Start
- Nov 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of 3-hydroxybutyrate (2 arms), sponsored by University of Southern California. Primary endpoint: Serum Brain-Derived Neurotrophic Factor. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
3-hydroxybutyrate
Beyond the preview
Go deeper on NCT07218497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218497.